ArticleOrphanet journal of rare diseases2022

Health technology assessment and price negotiation alignment for rare disorder drugs in Canada: Who benefits?

Nigel S B RawsonPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.